{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:51:23Z","timestamp":1783633883106,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6980","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1038\/nature02369","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T13:40:32Z","timestamp":1079530832000},"page":"332-337","source":"Crossref","is-referenced-by-count":796,"title":["Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy"],"prefix":"10.1038","volume":"428","author":[{"given":"Hans-Guido","family":"Wendel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa de","family":"Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Fridman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abba","family":"Malina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagarika","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cordon-Cardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnature02369_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000)","journal-title":"Cell"},{"key":"BFnature02369_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153\u2013164 (2002)","journal-title":"Cell"},{"key":"BFnature02369_CR3","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1074\/jbc.M108302200","volume":"277","author":"LD Mayo","year":"2002","unstructured":"Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K. & Donner, D. B. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484\u20135489 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature02369_CR4","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","volume":"13","author":"SR Datta","year":"1999","unstructured":"Datta, S. R., Brunet, A. & Greenberg, M. E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905\u20132927 (1999)","journal-title":"Genes Dev."},{"key":"BFnature02369_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489\u2013501 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature02369_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng0497-356","volume":"15","author":"PA Steck","year":"1997","unstructured":"Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet. 15, 356\u2013362 (1997)","journal-title":"Nature Genet."},{"key":"BFnature02369_CR7","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1182\/blood.V92.9.3410","volume":"92","author":"A Sakai","year":"1998","unstructured":"Sakai, A., Thieblemont, C., Wellmann, A., Jaffe, E. S. & Raffeld, M. PTEN gene alterations in lymphoid neoplasms. Blood 92, 3410\u20133415 (1998)","journal-title":"Blood"},{"key":"BFnature02369_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.leu.2402874","volume":"17","author":"YH Min","year":"2003","unstructured":"Min, Y. H. et al. Constitutive phosphorylation of Akt\/PKB protein in acute myeloid leukemia: its significance as a prognostic variable. Leukemia 17, 995\u2013997 (2003)","journal-title":"Leukemia"},{"key":"BFnature02369_CR9","doi-asserted-by":"publisher","first-page":"31515","DOI":"10.1074\/jbc.272.50.31515","volume":"272","author":"M Andjelkovic","year":"1997","unstructured":"Andjelkovic, M. et al. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 272, 31515\u201331524 (1997)","journal-title":"J. Biol. Chem."},{"key":"BFnature02369_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533\u2013538 (1985)","journal-title":"Nature"},{"key":"BFnature02369_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1535-6108(02)00047-8","volume":"1","author":"CA Schmitt","year":"2002","unstructured":"Schmitt, C. A. et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1, 289\u2013298 (2002)","journal-title":"Cancer Cell"},{"key":"BFnature02369_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/79542","volume":"6","author":"CA Schmitt","year":"2000","unstructured":"Schmitt, C. A., Rosenthal, C. T. & Lowe, S. W. Genetic analysis of chemoresistance in primary murine lymphomas. Nature Med. 6, 1029\u20131035 (2000)","journal-title":"Nature Med."},{"key":"BFnature02369_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0092-8674(02)00734-1","volume":"109","author":"CA Schmitt","year":"2002","unstructured":"Schmitt, C. A. et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109, 335\u2013346 (2002)","journal-title":"Cell"},{"key":"BFnature02369_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1471-4892(03)00071-7","volume":"3","author":"S Huang","year":"2003","unstructured":"Huang, S. & Houghton, P. J. Targeting mTOR signalling for cancer therapy. Curr. Opin. Pharmacol. 3, 371\u2013377 (2003)","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnature02369_CR15","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1074\/jbc.M010551200","volume":"276","author":"DR Plas","year":"2001","unstructured":"Plas, D. R., Talapatra, S., Edinger, A. L., Rathmell, J. C. & Thompson, C. B. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276, 12041\u201312048 (2001)","journal-title":"J. Biol. Chem."},{"key":"BFnature02369_CR16","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1091\/mbc.01-12-0584","volume":"13","author":"AL Edinger","year":"2002","unstructured":"Edinger, A. L. & Thompson, C. B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276\u20132288 (2002)","journal-title":"Mol. Biol. Cell"},{"key":"BFnature02369_CR17","doi-asserted-by":"publisher","first-page":"10314","DOI":"10.1073\/pnas.171076798","volume":"98","author":"MS Neshat","year":"2001","unstructured":"Neshat, M. S. et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP\/mTOR. Proc. Natl Acad. Sci. USA 98, 10314\u201310319 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature02369_CR18","first-page":"6141","volume":"62","author":"V Grunwald","year":"2002","unstructured":"Grunwald, V. et al. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res. 62, 6141\u20136145 (2002)","journal-title":"Cancer Res."},{"key":"BFnature02369_CR19","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.1073\/pnas.171060098","volume":"98","author":"K Podsypanina","year":"2001","unstructured":"Podsypanina, K. et al. An inhibitor of mTOR reduces neoplasia and normalizes p70\/S6 kinase activity in Pten+\/- mice. Proc. Natl Acad. Sci. USA 98, 10320\u201310325 (2001)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature02369_CR20","first-page":"886","volume":"59","author":"H Hosoi","year":"1999","unstructured":"Hosoi, H. et al. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells. Cancer Res. 59, 886\u2013894 (1999)","journal-title":"Cancer Res."},{"key":"BFnature02369_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","volume":"103","author":"T Schmelzle","year":"2000","unstructured":"Schmelzle, T. & Hall, M. N. TOR, a central controller of cell growth. Cell 103, 253\u2013262 (2000)","journal-title":"Cell"},{"key":"BFnature02369_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/345544a0","volume":"345","author":"A Lazaris-Karatzas","year":"1990","unstructured":"Lazaris-Karatzas, A., Montine, K. S. & Sonenberg, N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5\u2032 cap. Nature 345, 544\u2013547 (1990)","journal-title":"Nature"},{"key":"BFnature02369_CR23","doi-asserted-by":"publisher","first-page":"24776","DOI":"10.1074\/jbc.M001938200","volume":"275","author":"VA Polunovsky","year":"2000","unstructured":"Polunovsky, V. A. et al. Translational control of the antiapoptotic function of Ras. J. Biol. Chem. 275, 24776\u201324780 (2000)","journal-title":"J. Biol. Chem."},{"key":"BFnature02369_CR24","first-page":"637","volume-title":"Translational Control of Gene Expression","author":"JWB Hershey","year":"2000","unstructured":"Hershey, J. W. B. & Miyamoto, S. in Translational Control of Gene Expression (eds Sonenberg, N., Hershey, J. W. B. & Mathews, M. B.) 637\u2013654 (Cold Spring Harbor, New York, 2000)"},{"key":"BFnature02369_CR25","doi-asserted-by":"publisher","first-page":"22175","DOI":"10.1074\/jbc.M202014200","volume":"277","author":"A Grolleau","year":"2002","unstructured":"Grolleau, A. et al. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 277, 22175\u201322184 (2002)","journal-title":"J. Biol. Chem."},{"key":"BFnature02369_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1097-2765(03)00395-2","volume":"12","author":"VK Rajasekhar","year":"2003","unstructured":"Rajasekhar, V. K. et al. Oncogenic Ras and Akt signalling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol. Cell 12, 889\u2013901 (2003)","journal-title":"Mol. Cell"},{"key":"BFnature02369_CR27","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","volume":"13","author":"CA Schmitt","year":"1999","unstructured":"Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R. & Lowe, S. W. INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13, 2670\u20132677 (1999)","journal-title":"Genes Dev."},{"key":"BFnature02369_CR28","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1073\/pnas.97.3.1206","volume":"97","author":"M Yang","year":"2000","unstructured":"Yang, M. et al. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc. Natl Acad. Sci. USA 97, 1206\u20131211 (2000)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature02369_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/84879","volume":"27","author":"A Di Cristofano","year":"2001","unstructured":"Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C. & Pandolfi, P. P. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nature Genet. 27, 222\u2013224 (2001)","journal-title":"Nature Genet."},{"key":"BFnature02369_CR30","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1101\/gad.12.15.2434","volume":"12","author":"E de Stanchina","year":"1998","unstructured":"de Stanchina, E. et al. E1A signalling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12, 2434\u20132442 (1998)","journal-title":"Genes Dev."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature02369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02369","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature02369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:21:37Z","timestamp":1684419697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature02369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":30,"journal-issue":{"issue":"6980","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BFnature02369"],"URL":"https:\/\/doi.org\/10.1038\/nature02369","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1018142.206723","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1018142.207628","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}